Molecular structure of Eptaplatin, CAS Number: 146665-77-2
Eptaplatin (CAS 146665-77-2)
Application:
Eptaplatin is a platinum-based coordination compound
CAS Number:
146665-77-2
Purity:
≥99%
Molecular Weight:
471.36
Molecular Formula:
C11H20N2O6Pt
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Eptaplatin is a platinum-based coordination compound with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines. Like other platinum-based anticancer compounds, such as cisplatin and carboplatin, Eptaplatin exerts its antitumor effects by forming DNA adducts, which interfere with DNA replication and transcription, leading to cell death. By damaging the DNA, Eptaplatin prevents cancer cells from proliferating and spreading. Some expose cancer cell lines to various concentrations of Eptaplatin to assess its cytotoxic effects and measure cell viability.
Eptaplatin (CAS 146665-77-2) References
- Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs. | Jiang, M. and Milner, J. 2005. Methods Mol Biol. 292: 401-20. PMID: 15507723
- Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. | Niu, XY., et al. 2006. Int J Gynecol Cancer. 16: 743-51. PMID: 16681755
- Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. | Fujii, T., et al. 2006. Int J Oncol. 29: 541-8. PMID: 16865269
- Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate. | Yu, Y., et al. 2008. Eur J Med Chem. 43: 1438-43. PMID: 17959272
- Preparation, characterization and in vitro anticancer activity of platinum(II) complexes with N-Cyclohexyl-1,3-propanediamine as the carrier. | Liu, W., et al. 2008. Chem Pharm Bull (Tokyo). 56: 659-62. PMID: 18451553
- Functionalized Graphene Oxide as Drug Delivery Systems for Platinum Anticancer Drugs. | Wei, L., et al. 2021. J Pharm Sci. 110: 3631-3638. PMID: 34303674
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Eptaplatin, 10 mg | sc-218326 | 10 mg | $268.00 | |||
Eptaplatin, 100 mg | sc-218326A | 100 mg | $2183.00 |